Lyophilized Injectable Drugs to 2024

Wednesday, December 6, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 5, 2017 /PRNewswire/ -- The inherent instability of protein drugs is a limitation that has a direct impact

on the drug delivery sector. Therapeutic proteins must either be stored under special conditions or formulated to retain their efficacy from the time of manufacture until they are dispensed. Liquid protein drugs require refrigeration until dispensed
â€" a requirement referred to as the ‘cold chain’. Read the full report: https://www.reportlinker.com/p03620308Alternatively, proteins can be formulated as powders (lyophilization). Lyophilized proteins must be reconstituted prior to injection. Lyophilized drugs are sold with reconstitution vial systems, or packaged in special injection devices (e.g., pens, needle-free injectors, two-part syringes) that allow reconstitution to take place in the device prior to injection.What You Will Learn• Provides detailed analysis of lyophilized drugs, as-supplied packaging and therapeutic indication• Analyzes therapeutic demand drivers and evaluates lyophilized drugs in eleven therapeutic areas• Analyzes lyophilization technologies and market development issues• Provides market data and forecasts to 2024• Profiles market participants, their product development activities, business strategies, and corporate alliances and affiliations• Assesses the importance of technology and regulatory factors on commercialization and market access Read the full report: https://www.reportlinker.com/p03620308 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/lyophilized-injectable-drugs-to-2024-300567376.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store